CMC Workshop

To combat the increasing risk of falsified medicines in the global market many countries have or plan to initiate serialization and traceability requirements. The lack of coordination of these efforts has the potential to create conflicting requirements and complex operational challenges for all stakeholders in the pharmaceutical supply chain. This session will highlight the current challenges facing the pharmaceutical industry to track and trace global medicinal products, discuss harmonized approaches pertaining to serialization, and provide a regulator’s perspective to addressing falsified medicines. During the panel discussion, you will have the opportunity to ask questions and share ideas on approaches to secure pharmaceutical products supply chains to ensure that patients receive safe and effective medicinal products.